Avid Bioservices Inc (CDMO)

[biopharm]

Science DOES FAIL..

Must be BMY Opdivo failure that is leading them to the conclusion that they must have PS Targeting in a combo in order to have a chance

Imagine that, BMY failed to realize that only 20-30% of the patients in the trials responded to Opdivo ? 20-30%? that is the biggest failure

It is now Peregrine that has a blood test in the works, to prove which patients will benefit from PS Targeting--- now I wonder why BMY wouldn't move forward with a blood test ? LOL

Because if they ever declared their blood test, it would PROVE that PS Targeting is required

The biggest failure of all was BMY and now it may be too late to bring PS Targeting into Opdivo, because Memorial Sloan Kettering and Dr. Jedd Wolchok may show there is a better way